CC BY-NC-ND 4.0 · Revista Urología Colombiana / Colombian Urology Journal 2019; 28(02): 130-141
DOI: 10.1055/s-0038-1661364
Review Articles | Artículos de Revisión
Sociedad Colombiana de Urología. Publicado por Thieme Revinter Publicações Ltda Rio de Janeiro, Brazil

Biopsia transrectal ecodirigida de la próstata: estado del arte y guía práctica de consejos y trucos

Transrectal Ultrasound Biopsy of the Prostate: State of the Art and Practical Guide of Tip and Tricks
Julián Chavarriaga Soto
1   Residente de Urología, Pontificia Universidad Javeriana, Bogotá, Colombia
,
María Antonia Ocampo
2   Estudiante de Medicina, Universidad del Rosario, Bogotá, Colombia
,
Andrés Felipe Gutiérrez
3   Departamento de Urología, Hospital Universitario San Ignacio, Profesor Ad Honorem Pontificia Universidad Javeriana, Bogotá, Colombia
› Author Affiliations
Further Information

Publication History

21 March 2018

25 May 2018

Publication Date:
25 June 2018 (online)

Resumen

Introducción y Objetivos La biopsia transrectal de la próstata (BTRP), fue propuesta por primera vez en 1937 y hasta 1981 se realizó la primera biopsia ecodirigida, actualmente es la vía de acceso a la próstata más utilizada por su fácil curva de aprendizaje como por el alto rendimiento diagnóstico, sin embargo, en el Reino Unido, el 68% de los urólogos no realizan BTRP porque consideran que no han recibido suficiente entrenamiento. El objetivo de este estudio es describir las diferentes técnicas utilizadas en la actualidad, las complicaciones del procedimiento y aportar una guía de consejos y trucos implementada en varios centros de referencia a la hora de realizar una BTRP para prevenir complicaciones, mejorar el desempeño de la prueba y del urólogo y estandarizar el método de toma de la BTRP.

Materiales y Métodos Realizamos una búsqueda en las bases de datos de PubMed, MEDLINE, SciELO utilizando las palabras claves “Transrectal ultrasound biopsy of the prostate” “tips and tricks” “Transperineal biopsy of the prostate” “Magnetic resonance imaging targeted biopsy” “MRI/US fusion biopsy”, basados en la literatura y en la experiencia de los autores de más de 1100 biopsias anuales entre los diferentes centros de referencia. Brindamos una guía práctica de consejos y trucos para facilitar el desempeño del urólogo en la BTRP.

Resultados La biopsia transrectal de próstata ecodirigida continúa siendo la primera opción para el abordaje diagnóstico del paciente con sospecha clínica de cáncer de próstata, es de gran importancia estandarizar el esquema de toma de la biopsia, y en nuestro caso recomendamos utilizar un esquema de 12 cores, definir la profilaxis antibióticas y la duración del tratamiento, y el uso de analgesia o anestesia local. Presentamos los consejos y trucos que hemos utilizado en nuestra práctica clínica en varios centros de referencia.

Abstract

Introduction Transrectal biopsy of the prostate was described for the first time in 1937, and it was not until 1981 the first transrectal biopsy of the prostate was done using transrectal ultrasound to guide the procedure. Nowadays it is the most popular technique to obtain prostatic tissue when suspecting adenocarcinoma of the prostate, this due to its easy learning curve and to its excellent diagnostic performance. Up to 68% of urologist in the UK do not do prostate biopsy arguing they have not received enough training The aim of this article is to describe the different techniques, the physics of ultrasonography and a practical guide of tips and tricks from a center where we performed up to 1100 transrectal ultrasound biopsies annually, aiming to improve the diagnostic performance and lower the complicacion rates of the biopsy.

Methods We performed a search in PubMed, MEDLINE, SciELO using the keywords “Transrectal ultrasound biopsy of the prostate” “tips and tricks” “Transperineal biopsy of the prostate””Magnetic resonance imaging targeted biopsy” “MRI/US fusion biopsy,” and base on the literature review and our experience of more than a thousand biopsies annually we wrote this article.

Results TRUS biopsy of the prostate continue to be the first choice in the urologist armamentarium to diagnose the patient with clinical suspicion of prostate cáncer, with a low complication rate, a good diagnostic performance and an easy learning curve. It is necessary to standardized the procedure, perform a doble sextant biopsy, define the best antibiotic prophylaxis, the technique for anesthesia/analgesia. Here we present our practical guide of tips and tricks.

 
  • Bibliografía

  • 1 Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016; 66 (01) 7-30
  • 2 Logan JK, Rais-Bahrami S, Turkbey B. , et al. Current status of magnetic resonance imaging (MRI) and ultrasonography fusion software platforms for guidance of prostate biopsies. BJU Int 2014; 114 (05) 641-652
  • 3 Howlander N. (2004). SEER Cancer Statistics Review 1975–2004. http://seer.cáncer.gov/csr/1975_2004/
  • 4 Carroll PR, Parsons JK, Andriole G. , et al. NCCN guidelines insights: prostate cáncer early detection, version 2.2017. J Natl Compr Canc Netw 2016; 14 (05) 509-519
  • 5 Vickers AJ, Cronin AM, Björk T. , et al. Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study. BMJ 2010; 341: c4521
  • 6 Randazzo M, Müller A, Carlsson S. , et al. A positive family history as a risk factor for prostate cancer in a population-based study with organised prostate-specific antigen screening: results of the Swiss European Randomised Study of Screening for Prostate Cancer (ERSPC, Aarau). BJU Int 2016; 117 (04) 576-583
  • 7 Barocas DA, Grubb III R, Black A. , et al. Association between race and follow-up diagnostic care after a positive prostate cancer screening test in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer 2013; 119 (12) 2223-2229
  • 8 Presti Jr JC, O'Dowd GJ, Miller MC, Mattu R, Veltri RW. Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study. J Urol 2003; 169 (01) 125-129
  • 9 Ukimura O, Coleman JA, de la Taille A. , et al. Contemporary role of systematic prostate biopsies: indications, techniques, and implications for patient care. Eur Urol 2013; 63 (02) 214-230
  • 10 Schoots IG, Roobol MJ, Nieboer D, Bangma CH, Steyerberg EW, Hunink MG. Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis. Eur Urol 2015; 68 (03) 438-450
  • 11 Taira AV, Merrick GS, Galbreath RW. , et al. Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting. Prostate Cancer Prostatic Dis 2010; 13 (01) 71-77
  • 12 Yeo L, Patel D, Bach C. , et al. (2011). The development of the modern prostate biopsy. In Prostate Biopsy. InTech
  • 13 Herranz Amo F, Diéz Cordero JM, Cabello Benavente R. Evolución de la técnica de biopsia transrectal ecodirigida de la próstata. Arch Esp Urol 2006; 59 (04) 385-396
  • 14 Aarnink RG, Beerlage HP, De La Rosette JJ, Debruyne FM, Wijkstra H. Transrectal ultrasound of the prostate: innovations and future applications. J Urol 1998; 159 (05) 1568-1579
  • 15 Hodge KK, McNeal JE, Terris MK, Stamey TA. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989; b 142 (01) 71-74 , discussion 74–75
  • 16 Levine MA, Ittman M, Melamed J, Lepor H. Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer. J Urol 1998; 159 (02) 471-475 , discussion 475–476
  • 17 Mitterberger M, Horninger W, Aigner F. , et al. Ultrasound of the prostate. Cancer Imaging 2010; 10 (01) 40-48
  • 18 Wein AJ, Kavoussi LR, Campbell MF. 1. (2015). Campbell-Walsh urology (11th ed.). Philadelphia, PA: Elsevier Saunders;
  • 19 Patel U, Rickards D. (2002). Handbook of transrectal ultrasound and biopsy of the prostate . Taylor & Francis;
  • 20 Rodriguez Jr E, Skarecky D, Narula N, Ahlering TE. Prostate volume estimation using the ellipsoid formula consistently underestimates actual gland size. J Urol 2008; 179 (02) 501-503
  • 21 MacMahon PJ, Kennedy A-M, Murphy DT, Maher M, McNicholas MM. Modified prostate volume algorithm improves transrectal US volume estimation in men presenting for prostate brachytherapy. Radiology 2009; 250 (01) 273-280
  • 22 Ching CB, Moussa AS, Li J, Lane BR, Zippe C, Jones JS. Does transrectal ultrasound probe configuration really matter? End fire versus side fire probe prostate cancer detection rates. J Urol 2009; 181 (05) 2077-2082 , discussion 2082–2083
  • 23 Rojas AFG. Evaluación volumétrica de la próstata. Rev Urol Colombiana 2017; 26 (01) 74-75
  • 24 Kaye KW, Horwitz CA. Transrectal ultrasound-guided prostate biopsies using new automatic gun: analysis of 100 consecutive cases. J Endourol 1989; 3 (02) 155-161
  • 25 El-Hakim A, Moussa S. CUA guidelines on prostate biopsy methodology. Can Urol Assoc J 2010; 4 (02) 89-94
  • 26 Gonzalez C. , et al. AUA/SUNA White Paper on the Incidence, Prevention and Treatment of Complications Related to Prostate Needle Biopsy
  • 27 Stinchcomb S. AUA/Optimal Techniques of Prostate Biopsy and Specimen Handling (White paper)
  • 28 Kam SC, Choi SM, Yoon S. , et al. Complications of transrectal ultrasound-guided prostate biopsy: impact of prebiopsy enema. Korean J Urol 2014; 55 (11) 732-736
  • 29 Chiang IN, Chang SJ, Pu YS, Huang KH, Yu HJ, Huang CY. Major complications and associated risk factors of transrectal ultrasound guided prostate needle biopsy: a retrospective study of 1875 cases in taiwan. J Formos Med Assoc 2007; 106 (11) 929-934
  • 30 Nam RK, Saskin R, Lee Y. , et al. Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol 2010; 183 (03) 963-968
  • 31 Loeb S, Vellekoop A, Ahmed HU. , et al. Systematic review of complications of prostate biopsy. Eur Urol 2013; 64 (06) 876-892
  • 32 Nazir B. Pain during transrectal ultrasound-guided prostate biopsy and the role of periprostatic nerve block: what radiologists should know. Korean J Radiol 2014; 15 (05) 543-553
  • 33 Hwang EC, Jung SI, Seo YH. , et al. Risk factors for and prophylactic effect of povidone-iodine rectal cleansing on infectious complications after prostate biopsy: a retrospective cohort study. Int Urol Nephrol 2015; 47 (04) 595-601
  • 34 Saade EA, Suwantarat N, Zabarsky TF, Wilson B, Donskey CJ. Fluoroquinolone-Resistant Escherichia coli Infections After Transrectal Biopsy of the Prostate in the Veterans Affairs Healthcare System. Pathog Immun 2016; 1 (02) 243-257
  • 35 Castelblanco DM, Gómez F, Cataño JG, Plata M, Trujillo CG. Cultivo rectal para detección de gérmenes resistentes a fluoroquinolonas y reducción de riesgo de bacteriemia en pacientes llevados a biopsia de próstata en un hospital de nivel IV de atención. Univ Méd 2015; 56 (01) xx
  • 36 Womble PR, Dixon MW, Linsell SM. , et al; Michigan Urological Surgery Improvement Collaborative. Infection related hospitalizations after prostate biopsy in a statewide quality improvement collaborative. J Urol 2014; 191 (06) 1787-1792
  • 37 Walker JT, Singla N, Roehrborn CG. Reducing Infectious Complications Following Transrectal Ultrasound-guided Prostate Biopsy: A Systematic Review. Rev Urol 2016; 18 (02) 73-89
  • 38 Roethke M, Anastasiadis AG, Lichy M. , et al. MRI-guided prostate biopsy detects clinically significant cancer: analysis of a cohort of 100 patients after previous negative TRUS biopsy. World J Urol 2012; 30 (02) 213-218
  • 39 Abdollah F, Novara G, Briganti A. , et al. Trans-rectal versus trans-perineal saturation rebiopsy of the prostate: is there a difference in cancer detection rate?. Urology 2011; 77 (04) 921-925
  • 40 National Comprehensive Cancer Network. Prostate early detection (Version 2.2016). https://www.nccn.org/professionals/physician_gls/PDF/prostate_detection.pdf
  • 41 Hamdy FC, Donovan JL, Lane JA. , et al; ProtecT Study Group. 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med 2016; 375 (15) 1415-1424
  • 42 Ahmed HU, El-Shater Bosaily A, Brown LC. , et al; PROMIS study group. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet 2017; 389 (10071): 815-822
  • 43 Rosenkrantz AB, Verma S, Choyke P. , et al. Prostate magnetic resonance imaging and magnetic resonance imaging targeted biopsy in patients with a prior negative biopsy: a consensus statement by AUA and SAR. J Urol 2016; 196 (06) 1613-1618
  • 44 Marks L, Young S, Natarajan S. MRI-ultrasound fusion for guidance of targeted prostate biopsy. Curr Opin Urol 2013; 23 (01) 43-50
  • 45 Kasivisvanathan V, Rannikko AS, Borghi M. , et al; PRECISION Study Group Collaborators. MRI-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med 2018; 378 (19) 1767-1777
  • 46 Mottet N, Bellmunt J, Bolla M. , et al. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol 2017; 71 (04) 618-629
  • 47 Saleem MD, Sanders H, Abu El Naser M, El-Galley R. Factors predicting cancer detection in biopsy of the prostatic fossa after radical prostatectomy. Urology 1998; 51 (02) 283-286
  • 48 Naya Y, Okihara K, Evans RB, Babaian RJ. Efficacy of prostatic fossa biopsy in detecting local recurrence after radical prostatectomy. Urology 2005; 66 (02) 350-355
  • 49 Deliveliotis C, Manousakas T, Chrisofos M, Skolarikos A, Delis A, Dimopoulos C. Diagnostic efficacy of transrectal ultrasound-guided biopsy of the prostatic fossa in patients with rising PSA following radical prostatectomy. World J Urol 2007; 25 (03) 309-313
  • 50 Prostate Cancer: Clinical Practice Guideline in Oncology. NCCN; 2017
  • 51 Prostate Cancer: diagnosis and treatment. Commissioned by the National Institute for Health and Care Excellence; 2014